title: High B-Type Natriuretic Peptide Hypertensives at Target Blood Pressure: Potential Role of β-Blockers to Reduce Their Elevated Risk.
authors.affiliation: From the Division of Cardiovascular and Diabetes Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, Scotland. a.d.struthers@dundee.ac.uk.
authors.forename: Allan D
authors.initials: AD
authors.lastname: Struthers
authors.affiliation: From the Division of Cardiovascular and Diabetes Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, Scotland.
authors.forename: Jacob
authors.initials: J
authors.lastname: George
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology*; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000517:prevention & control; D003362:Cost-Benefit Analysis; D006331:Heart Diseases / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology*; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D010446:Peptide Fragments / Q000097:blood*; D012307:Risk Factors; D020521:Stroke / Q000453:epidemiology / Q000517:prevention & control; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D015415:Biomarkers; D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain